M&A Deal Summary

SJL Partners and SD BioSensor Acquire Meridian Bioscience

On July 7, 2022, private equity firm SJL Partners and SD BioSensor acquired life science company Meridian Bioscience for 1.5B USD

Acquisition Highlights
  • This is SJL Partners’ 1st and SD BioSensor’s 1st transaction in the Life Science sector.
  • This is SJL Partners’ 2nd and SD BioSensor’s largest (disclosed) transaction.
  • This is SJL Partners’ 2nd and SD BioSensor’s 1st transaction in the United States.
  • This is SJL Partners’ 1st and SD BioSensor’s 1st transaction in Ohio.

M&A Deal Summary
Date 2022-07-07
Target Meridian Bioscience
Sector Life Science
Buyer(s) SJL Partners
SD BioSensor
Deal Type Add-on Acquisition
Deal Value 1.5B USD
Advisor(s) Rothschild Global Advisory (Financial)
Jones Day
Keating Muething & Klekamp (Legal)

Target

Meridian Bioscience

Cincinnati, Ohio, United States
website
Meridian is a life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Meridian was founded in 1976 and is based in Cincinnati, Ohio.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 2

Buyer

SJL Partners

Investor Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2017
Size Small
Type Sector Agnostic
DESCRIPTION

SJL Partners is a private equity firm that looks for long-term investment opportunities in South Korea. The Firm looks to partner with management and generally targets businesses exhibiting sustainable growth opportunities. SJL Partners was formed in 2017 and is headquartered in Seoul.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ohio) 1 of 1
Country (United States) 2 of 2
Year (2022) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-13 Momentive

Schenectady, New York, United States

Momentive is a global advanced materials company with a cutting-edge focus on silicone and specialty products. The company delivers technologies, solutions, and processes designed to propel customers' products forward products that have a profound impact on everyday life from dawn to dusk, and from living rooms to outer space. Momentive is based in Schenectady, New York.

Buy $3.1B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-28 Momentive

Schenectady, New York, United States

Momentive is a global advanced materials company with a cutting-edge focus on silicone and specialty products. The company delivers technologies, solutions, and processes designed to propel customers' products forward products that have a profound impact on everyday life from dawn to dusk, and from living rooms to outer space. Momentive is based in Schenectady, New York.

Sell -
Buyer

SD BioSensor

Suwon, South Korea

website

Category Company
Founded 2010
Sector Life Science
Revenue 2,930.0B KRW (2021)
DESCRIPTION

SD BioSensor is a global in-vitro diagnostics company that contributes to improving quality of life by quickly and accurately diagnosing diseases under the slogan 'Beginning of all things that protect lives.' SD Biosensor is a Total Solution Provider in the IVD industry, developing and researching innovative diagnostic platforms. SD BioSensor was founded in 2010 and is based in Suwon, South Korea.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ohio) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal